Dominari (NASDAQ:DOMH) Stock Price Up 6.5% - Should You Buy?

Dominari Holdings Inc. (NASDAQ:DOMH - Get Free Report)'s stock price rose 6.5% on Monday . The stock traded as high as $6.11 and last traded at $5.88. Approximately 128,153 shares changed hands during trading, a decline of 66% from the average daily volume of 378,101 shares. The stock had previously closed at $5.52.

Analyst Ratings Changes

Several analysts recently commented on DOMH shares. Weiss Ratings reiterated a "sell (d-)" rating on shares of Dominari in a report on Wednesday, October 8th. Wall Street Zen upgraded Dominari from a "sell" rating to a "buy" rating in a report on Saturday, August 16th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Dominari currently has an average rating of "Sell".

Dominari Trading Up 6.5%

The firm has a market capitalization of $91.40 million, a PE ratio of -2.48 and a beta of 0.75. The business has a 50-day moving average of $6.38 and a 200 day moving average of $5.47.

Dominari (NASDAQ:DOMH - Get Free Report) last announced its earnings results on Monday, August 11th. The company reported ($1.02) earnings per share (EPS) for the quarter. Dominari had a negative net margin of 36.01% and a negative return on equity of 94.32%. The business had revenue of $34.10 million for the quarter.

Dominari Dividend Announcement

The company also recently disclosed a special dividend, which was paid on Friday, September 26th. Investors of record on Wednesday, September 3rd were paid a dividend of $0.22 per share. The ex-dividend date of this dividend was Wednesday, September 3rd.

Institutional Investors Weigh In On Dominari

A number of institutional investors and hedge funds have recently bought and sold shares of DOMH. Connective Capital Management LLC bought a new stake in Dominari in the 2nd quarter worth approximately $1,446,000. PFG Investments LLC bought a new stake in Dominari in the 1st quarter worth approximately $566,000. Jane Street Group LLC bought a new stake in Dominari in the 2nd quarter worth approximately $158,000. Magnus Financial Group LLC bought a new stake in Dominari in the 2nd quarter worth approximately $136,000. Finally, Geode Capital Management LLC lifted its position in Dominari by 2.9% in the 2nd quarter. Geode Capital Management LLC now owns 66,283 shares of the company's stock worth $361,000 after buying an additional 1,866 shares during the last quarter. 42.48% of the stock is owned by hedge funds and other institutional investors.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.